PERFORMANCE FEATURES OF MEGACLUSTERS IN THE PHARMACEUTICAL INDUSTRY
Currently, in the global pharmaceutical market, mega-clusters are becoming extremely important, which ensure the effective interaction of the largest producers, suppliers, investors and other economic agents. The aim of the work is to consider and compare development models of megaclusters in the pharmaceutical industry, to determine drivers and barriers to their growth. Based on the analysis of the clusters performance of the three mega-regions (North and South America, Western Europe, the Asia-Pacific region), the latest trends in the development of the pharmaceutical market and key factors in the growth of the pharmaceutical industry are revealed.
Keywords: pharmaceutical industry, global market, megacluster, development model, regionalization, growth drivers, growth barriers.
Highlights:
the classification of pharmaceutical clusters of three mega-regions (North and South America, Western Europe, Asia-Pacific region) is proposed and carried out;
the analysis of pharmaceutical mega-clusters performance is carried out;
the drivers and growth barriers of pharmaceutical clusters of the three mega-regions are singled out, the development vector of the global pharmaceutical industry is determined.
Igor A. Karachev, Candidate of Economics, Associate Professor; Alena I. Volkova, Candidate of Economics, assistant. – P. G. Demidov Yaroslavl State University.